China Universal Asset Management Company’s Neumora Therapeutics NMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$23.8K Buy
2025
Q1
$32.4K Sell
2024
Q4
$363K Buy